Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 84
Filter
1.
Med. lab ; 27(1): 33-38, 2023. ilus
Article in Spanish | LILACS | ID: biblio-1412750

ABSTRACT

El hemangiolinfangioma es un tipo muy raro de malformación del sistema vascular, caracterizado histológicamente por la presencia de vasos venosos y linfáticos dilatados quísticamente, cuyas células endoteliales de revestimiento son positivas para marcadores de inmunohistoquímica como CD31, CD34 y D2-40. El compromiso extenso retroperitoneal y del tracto gastrointestinal es infrecuente. Se presenta el caso de una paciente femenina de 24 años con antecedente de dolor pélvico crónico, con exacerbación de síntomas. El diagnóstico imagenológico mostró una masa retroperitoneal multiquística. Se hizo hemicolectomía derecha y resección de la masa, encontrándose que dicha lesión estaba íntimamente adherida al mesenterio con compromiso extenso del tracto gastrointestinal, y cuyo estudio histopatológico reveló un hemangiolinfangioma, con mejoría clínica posterior a la resección quirúrgica. Aportamos a la literatura mundial, la caracterización de los hallazgos clínicos, imagenológicos e histopatológicos de este tipo de malformaciones


Hemangiolymphangioma is a very rare type of malformation of the vascular system, characterized histologically by the presence of cystically dilated venous and lymphatic vessels, whose lining endothelial cells are positive for immunohistochemical markers such as CD31, CD34 and D2-40. Extensive retroperitoneal and gastrointestinal tract involvement is uncommon. We present the case of a 24-yearold female patient with a history of chronic pelvic pain with exacerbation of symptoms. The imaging diagnosis revealed a multicystic retroperitoneal mass. A right hemicolectomy and resection of the mass was performed, finding that the lesion was intimately adherent to the mesentery with extensive involvement of the gastrointestinal tract, and whose histopathological study revealed a hemangiolymphangioma, with clinical improvement after surgical resection. We contribute to the world literature with the characterization of the clinical, imaging and histopathological findings of this type of malformations


Subject(s)
Humans , Female , Young Adult , Peritoneal Neoplasms/diagnosis , Hemangioma/diagnosis , Lymphangioma/diagnosis , Mesentery/pathology , Peritoneal Neoplasms/surgery , Peritoneal Neoplasms/pathology , Endothelial Cells/pathology , Vascular Malformations/diagnosis , Vascular Malformations/pathology , Hemangioma/surgery , Hemangioma/pathology , Lymphangioma/surgery , Lymphangioma/pathology
2.
Andes Pediatr ; 93(2): 265-269, 2022 Apr.
Article in Spanish | MEDLINE | ID: mdl-35735307

ABSTRACT

Cystic lymphatic malformation (CLM) is a rare and benign entity caused by alterations in the embryological development of lymphatic structures. Its typical location is in the head and neck, although it has also been described at the abdominal level. It may not be evident in the first stages of life and its first manifestation may be a complication such as abdominal distension, hemorrhage, or sepsis, which may put the patient's life at risk. Surgical treatment is increasingly discussed, and less invasive techniques are proposed. OBJECTIVE: To describe an uncommon presentation of CLM, radiographic findings, complications, differential diagnosis, and both invasive and more conservative treatments. CLINICAL CASE: Newborn female infant consulted for fever and irritability, without specific signs on physical examination, with suspicion of sepsis. Ultrasonography showed a complex septate mass with cysts of different sizes encompassing the mesenteric vessels, supravesical location. In its most ante rior aspect, it presented a greater echogenicity that corresponded to the superinfected component. Magnetic resonance imaging identified a multitabulated cystic tumor corresponding to a complica ted mesenteric lymphangioma with signs of infection. Due to its size, which compressed the vena cava and the associated signs of complication, complete resection was decided with good subsequent evolution. CONCLUSION: The treatment of CLM in pediatric age is increasingly individualized and can vary from surgical resection to less invasive approaches that could reduce acute intraoperative or postoperative complications and mortality. In our case, the infection acted as sclerotherapy, mana ging to delimit the CLM and helping to improve the prognosis.


Subject(s)
Lymphangioma, Cystic , Lymphatic Abnormalities , Neonatal Sepsis , Child , Citrobacter freundii , Female , Humans , Infant , Infant, Newborn , Lymphangioma, Cystic/diagnostic imaging , Lymphangioma, Cystic/surgery , Lymphatic Abnormalities/pathology , Mesentery/pathology , Neonatal Sepsis/pathology
3.
Sci Rep ; 9(1): 14620, 2019 10 10.
Article in English | MEDLINE | ID: mdl-31601823

ABSTRACT

Galectin-3 (Gal-3) controls intercellular and cell-extracellular matrix interactions during immunological responses. In chronic inflammation, Gal-3 is associated with fibrotic events, regulates B cell differentiation and delays lupus progression. Gal-3 deficient mice (Lgals3-/-) have intense germinal center formation and atypical plasma cell generation correlated to high levels IgG, IgE, and IgA. Here, we used pristane (2,6,10,14-tetramethylpentadecane) to induce lupus-like syndrome in Lgals3-/- and Lgals3+/+ BALB/c mice. Mesentery and peritoneal cells were monitored because promptly react to pristane injected in the peritoneal cavity. For the first time, mesenteric tissues have been associated to the pathogenesis of experimental lupus-like syndrome. In Lgals3+/+ pristane-induced mice, mesentery was hallmarked by intense fibrogranulomatous reaction restricted to submesothelial regions and organized niches containing macrophages and B lymphocytes and plasma cells. In contrast, Lgals3-/- pristane-treated mice had diffuse mesenteric fibrosis affecting submesothelium and peripheral tissues, atypical M1/M2 macrophage polarization and significant DLL1+ cells expansion, suggesting possible involvement of Notch/Delta pathways in the disease. Early inflammatory reaction to pristane was characterized by significant disturbances on monocyte recruitment, macrophage differentiation and dendritic cell (DC) responses in the peritoneal cavity of pristane-induced Lgals3-/- mice. A correlative analysis showed that mesenteric damages in the absence of Gal-3 were directly associated with severe portal inflammation and hepatitis. In conclusion, it has suggested that Gal-3 orchestrates histological organization in the mesentery and prevents lupoid hepatitis in experimental lupus-like syndrome by controlling macrophage polarization, Notch signaling pathways and DC differentiation in mesenteric structures.


Subject(s)
Galectin 3/metabolism , Hepatitis/immunology , Lupus Erythematosus, Systemic/immunology , Macrophages, Peritoneal/immunology , Mesentery/pathology , Animals , Disease Models, Animal , Female , Fibrosis , Galectin 3/genetics , Hepatitis/pathology , Humans , Injections, Intraperitoneal , Liver/immunology , Liver/pathology , Lupus Erythematosus, Systemic/chemically induced , Lupus Erythematosus, Systemic/complications , Mesentery/cytology , Mesentery/immunology , Mice , Mice, Knockout , Terpenes/administration & dosage , Terpenes/immunology
4.
PLoS One ; 14(9): e0223105, 2019.
Article in English | MEDLINE | ID: mdl-31557250

ABSTRACT

Chronic/abnormal activation of endoplasmic reticulum (ER) stress is linked to the exacerbation of the inflammatory process and has been recently linked to Crohn's disease (CD) pathophysiology. We investigated the intestinal mucosa and the mesenteric adipose tissue (MAT) collected from CD patients with active disease (CD group) and from non-IBD patients (CTR group) to study ER stress activation and to address tissue-specific modulation in CD. The intestinal mucosa of CD patients showed an upregulation in the expression of ER stress related genes, including ATF3, DNAJC3, STC2, DDIT3, CALR, HSPA5 and HSP90B1. Results showed that EIF2AK3 gene was upregulated, along with increased protein expression of p-eIF2α and p-eIF2α/eIF2α ratio. Additionally, ERN1 gene expression was upregulated, along with an increased spliced/activated form sXBP1 protein. Despite the upregulation of ATF6 gene expression in the intestinal mucosa of CD patients, no differences were found in ATF6 protein expression. Lastly, the analysis of MAT revealed unchanged levels of ER stress markers along with no differences in the activation of UPR. However, chaperone gene expression was modulated in the MAT of CD patients. To conclude, our results address tissue-specific differences in UPR activation in CD and point the ER stress as an important pro-inflammatory mechanism in CD, specifically in the intestinal mucosa.


Subject(s)
Colon/pathology , Crohn Disease/immunology , Endoplasmic Reticulum Stress/immunology , Intestinal Mucosa/pathology , Intra-Abdominal Fat/pathology , Adult , Aged , Biomarkers/metabolism , Case-Control Studies , Colon/diagnostic imaging , Colon/immunology , Colonoscopy , Crohn Disease/diagnosis , Crohn Disease/pathology , Endoplasmic Reticulum Chaperone BiP , Female , Humans , Intestinal Mucosa/diagnostic imaging , Intestinal Mucosa/immunology , Intra-Abdominal Fat/immunology , Male , Mesentery/immunology , Mesentery/pathology , Middle Aged , Molecular Chaperones/metabolism , Severity of Illness Index , Symptom Flare Up , Unfolded Protein Response/immunology , Up-Regulation , Young Adult
5.
Cir Pediatr ; 32(3): 154-157, 2019 Jul 29.
Article in Spanish | MEDLINE | ID: mdl-31486309

ABSTRACT

INTRODUCTION: Calcifying fibrous pseudotumor is a rare benign lesion with few peritoneal and mesenteric cases in pediatric population described. Its course is mainly asymptomatic, which is why diagnosis corresponds mostly to incidental findings. CLINICAL CASE: Authors present the case of a 9-year-old patient with abdominal pain, and intra-abdominal mass finding in abdominal tomography. The histopathological study realized established diagnosis of calcifying fibrous pseudotumor, which is why programmed resection of the mass was performed by laparotomy. Follow-up was performed during one year, without evidence of recurrences through ecography. COMMENTS: Authors discuss the diagnostic and therapeutic approach in this patient compared to that described in the literature.


INTRODUCCION: El pseudotumor fibroso calcificado es una lesión benigna, con pocos casos de localización peritoneal y mesentérica descritos en la población pediátrica. Su curso es principalmente asintomático, por lo cual el diagnóstico corresponde en su mayoría a hallazgos incidentales. CASO CLINICO: Se presenta el caso de una paciente de 9 años con dolor abdominal y hallazgo de masa entra-abdominal en tomografía de abdomen. El estudio histopatológico realizado estableció el diagnóstico de pseudotumor fibroso calcificado, por lo que se llevó a resección programada de la masa mediante laparotomía. El seguimiento de la paciente fue durante un año, sin evidencia de recurrencias en ecografía. COMENTARIOS: Se discute la aproximación diagnóstica y terapéutica en esta paciente comparado con lo descrito en la literatura.


Subject(s)
Laparotomy/methods , Mesentery/pathology , Peritoneal Diseases/diagnosis , Abdominal Pain/etiology , Calcinosis/pathology , Child , Female , Follow-Up Studies , Humans , Peritoneal Diseases/pathology , Peritoneal Diseases/surgery , Tomography, X-Ray Computed/methods
6.
Rev. cir. (Impr.) ; 71(2): 168-172, abr. 2019. ilus
Article in Spanish | LILACS | ID: biblio-1058251

ABSTRACT

OBJETIVO: Reportar el caso de un paciente con antecedente de múltiples cirugías por peritonitis y abdomen abierto, con hallazgo intraoperatorio de osificación heterotópica en el mesenterio. CASO CLÍNICO: Paciente masculino de 59 años, con antecedente de apendicectomía complicada hace 12 meses, que en esa oportunidad requirió manejo de abdomen abierto, colectomía derecha e ileostomía terminal. Un año posapendicectomía reingresa para reconstitución de tránsito con hallazgo intraoperatorio de masa calcificada en mesenterio, de 15 x 10 x 6 cm, cuyo estudio histológico informa osificación heterotópica mesentérica. Esta entidad es de baja frecuencia, asociada al antecedente de trauma y cirugía abdominal, y se ha descrito como causa de morbimortalidad. El manejo quirúrgico resectivo es factible por equipos con experiencia. CONCLUSIÓN: Se describe un caso con antecedente de abdomen abierto, con posterior hallazgo de osificación heterotópica mesentérica. Este caso clínico es representativo por sus factores de riesgos clásicos y manejo empleado para su resolución.


OBJECTIVE: Report the case of a patient with a history of multiple surgeries due to peritonitis and open abdomen, with intraoperative finding of mesenetrioc heterotopic ossification. CLINICAL CASE: A 59-year-old male patient with a history of complicated appendectomy 12 months ago, which requires the management of an open abdomen, right colectomy and terminal ileostomy. One year after appendectomy, is readmitted for transit reconstitution. Intraoperative finding were calcified mass in mesentery, of 15 x 10 x 6 cm, whose histological study reports mesenteric heterotopic ossification. This entity has low frequency, and is associated with a history of trauma and abdominal surgery, is described as a cause of morbidity and mortality. Resective surgical management is feasible for experienced teams. CONCLUSION: A case with antecedent of open abdomen is described, with later finding of mesenteric heterotopic ossification. This clinical case is representative for its classic risk factors and management used for its resolution.


Subject(s)
Humans , Male , Middle Aged , Appendectomy/adverse effects , Peritoneal Diseases/etiology , Ossification, Heterotopic/etiology , Mesentery/pathology , Peritoneal Diseases/surgery , Ossification, Heterotopic/surgery
9.
Am J Surg Pathol ; 41(1): 128-133, 2017 01.
Article in English | MEDLINE | ID: mdl-27684993

ABSTRACT

Mesenteric tumor deposits (MTDs) are not included in the American Joint Committee on Cancer (AJCC) staging system for midgut small intestinal neuroendocrine tumors (NETs). We examined the prognostic significance of MTDs associated with midgut NETs. Hematoxylin and eosin slides from 132 resected jejunal/ileal NETs were reviewed for AJCC tumor stage, lymph node (LN) metastasis, MTDs, and hepatic metastases. MTDs were defined as discrete irregular mesenteric tumor nodules discontinuous from the primary tumor. Clinical or pathologic evidence of metastases and survival data were abstracted from electronic medical records. The cohort included 72 male and 60 female patients with a median age of 60 years. LN metastasis, MTDs, and liver metastasis were present in 80%, 68%, and 58% of patients, respectively. Female sex and presence of MTDs were independent predictors of liver metastasis. The odds ratio for hepatic metastasis in the presence of MTDs was 16.68 (95% confidence interval [CI], 4.66-59.73) and 0.81 (95% CI, 0.20-3.26) for LN metastasis. Age, MTDs, and hepatic metastasis were associated with disease-specific survival (DSS) in univariate analysis. Primary tumor histologic grade, pT3/T4 stage, and LN metastasis were not associated with DSS. Multivariate analysis of liver metastasis-free survival stratified by tumor grade showed that MTDs were associated with adverse outcomes. The hazard ratio for MTDs was 4.58 (95% CI, 1.89-11.11), compared with 0.98 (95% CI, 0.47-2.05) for LN metastasis. MTDs, but not LN metastasis, in midgut NETs are a strong predictor for hepatic metastasis and are associated with poor DSS.


Subject(s)
Intestinal Neoplasms/pathology , Mesentery/pathology , Neuroendocrine Tumors/pathology , Adult , Aged , Aged, 80 and over , Disease-Free Survival , Female , Humans , Intestinal Neoplasms/mortality , Intestine, Small/pathology , Kaplan-Meier Estimate , Liver Neoplasms/mortality , Liver Neoplasms/secondary , Lymphatic Metastasis/pathology , Male , Middle Aged , Neuroendocrine Tumors/mortality , Prognosis , Proportional Hazards Models , Young Adult
10.
Sci Rep ; 6: 28573, 2016 06 29.
Article in English | MEDLINE | ID: mdl-27353032

ABSTRACT

Intestinal inflammation can be induced by the reconstitution of T/B cell-deficient mice with low numbers of CD4(+) T lymphocytes depleted of CD25(+)Foxp3(+) regulatory T cells (Treg). Using RAG-knockout mice as recipients of either splenocytes exclusively depleted of CD25(+) cells or FACS-purified CD4(+)CD25(-)Foxp3(-) T cells, we found that the augmentation of potentially colitogenic naïve T cell numbers in the inoculum was unexpectedly beneficial for the suppression of colon disease and maintenance of immune homeostasis. Protection against T cell-mediated colitis correlated with a significant increment in the frequency of peripherally-induced CD4(+)CD25(+)Foxp3(+) T (pTreg) cells, especially in the mesenteric lymph nodes, an effect that required the presence of B cells and CD4(+)CD25(-)Foxp3(+) cells in physiological proportions. Our findings support a model whereby the interplay between B lymphocytes and a diversified naïve T cell repertoire is critical for the generation of CD4(+)CD25(+)Foxp3(+) pTreg cells and colitis suppression.


Subject(s)
B-Lymphocytes/immunology , Colitis/immunology , Colitis/prevention & control , Models, Immunological , T-Lymphocytes, Regulatory/immunology , Animals , B-Lymphocytes/pathology , Colitis/genetics , Colitis/pathology , Lymph Nodes/immunology , Lymph Nodes/pathology , Mesentery/immunology , Mesentery/pathology , Mice , Mice, Knockout , T-Lymphocytes, Regulatory/pathology
11.
Cir Cir ; 83(6): 522-6, 2015.
Article in Spanish | MEDLINE | ID: mdl-26144269

ABSTRACT

BACKGROUND: Small bowel volvulus is a rare cause of intestinal obstruction in adult patients. This disease is more common in children and its aetiology and management is different to that in adults. CLINICAL CASE: A 30 year-old male with sarcoidosis presents with acute abdomen and clinical data of intestinal obstruction. Small bowel volvulus is diagnosed by a contrast abdominal tomography and an exploratory laparotomy is performed with devolvulation and no intestinal resection. In the days following surgery, he developed a recurrent small bowel volvulus, which was again managed with surgery, but without intestinal resection. Medical treatment for sarcoidosis was started, and with his clinical progress being satisfactory,he was discharged to home. CONCLUSIONS: Making an early and correct diagnosis of small bowel volvulus prevents large intestinal resections. Many surgical procedures have been described with a high rate of complications. Therefore, conservative surgical management (no intestinal resection) is recommended as the best treatment with the lowest morbidity and mortality rate.


Subject(s)
Intestinal Volvulus/surgery , Intestine, Small/surgery , Adult , Humans , Ileus/etiology , Immunosuppressive Agents/therapeutic use , Incidence , Intestinal Obstruction/etiology , Intestinal Volvulus/complications , Intestinal Volvulus/diagnostic imaging , Intestinal Volvulus/epidemiology , Intestine, Small/diagnostic imaging , Intestine, Small/pathology , Laparotomy , Male , Mesentery/pathology , Postoperative Complications/etiology , Recurrence , Sarcoidosis/complications , Sarcoidosis/drug therapy , Tomography, Spiral Computed
12.
Acta Cir Bras ; 30(6): 439-44, 2015 Jun.
Article in English | MEDLINE | ID: mdl-26108033

ABSTRACT

PURPOSE: To evaluate whether post-hemorrhagic shock mesenteric lymph (PSML) is involved in cardiac dysfunction induced by hemorrhagic shock. METHODS: The hemorrhagic shock model (40±2 mmHg, 3h) was established in rats of the shock and shock+drainage groups; and PSML drainage was performed from hypotension 1-3h in the shock+drainage rats. Then, the isolated hearts were obtained from the rats for the examination of cardiac function with Langendorff system. Subsequently, the isolated hearts were obtained from normal rats and perfused with PSML or Krebs-Henseleit solution, and the changes of cardiac function were observed. RESULTS: The left ventricular systolic pressure (LVSP) and the maximal rates of LV developed pressure (LVDP) rise and fall (±dP/dt max) in the shock and shock+drainage groups were lower than that of the sham group; otherwise, these indices in the shock+drainage group were higher compared to the shock group. In addition, after isolated hearts obtained from normal rats perfusing with PSML, these cardiac function indices were gradual decline along with the extension of time, such as heart rate, LVSP, ±dP/dt max, etc. CONCLUSION: Post-hemorrhagic shock mesenteric lymph is an important contributor to cardiac dysfunction following hemorrhagic shock.


Subject(s)
Heart Diseases/etiology , Heart Diseases/physiopathology , Lymph/physiology , Mesentery/physiopathology , Shock, Hemorrhagic/complications , Shock, Hemorrhagic/physiopathology , Animals , Disease Models, Animal , Drainage/methods , Glucose , Heart Rate/physiology , Heart Ventricles/physiopathology , Male , Mesentery/pathology , Random Allocation , Rats, Wistar , Reference Values , Time Factors , Tromethamine , Ventricular Pressure/physiology
13.
Acta cir. bras ; Acta cir. bras;30(6): 439-444, 06/2015. graf
Article in English | LILACS | ID: lil-749641

ABSTRACT

PURPOSE: To evaluate whether post-hemorrhagic shock mesenteric lymph (PSML) is involved in cardiac dysfunction induced by hemorrhagic shock. METHODS: The hemorrhagic shock model (40±2 mmHg, 3h) was established in rats of the shock and shock+drainage groups; and PSML drainage was performed from hypotension 1-3h in the shock+drainage rats. Then, the isolated hearts were obtained from the rats for the examination of cardiac function with Langendorff system. Subsequently, the isolated hearts were obtained from normal rats and perfused with PSML or Krebs-Henseleit solution, and the changes of cardiac function were observed. RESULTS: The left ventricular systolic pressure (LVSP) and the maximal rates of LV developed pressure (LVDP) rise and fall (±dP/dt max) in the shock and shock+drainage groups were lower than that of the sham group; otherwise, these indices in the shock+drainage group were higher compared to the shock group. In addition, after isolated hearts obtained from normal rats perfusing with PSML, these cardiac function indices were gradual decline along with the extension of time, such as heart rate, LVSP, ±dP/dt max, etc. CONCLUSION: Post-hemorrhagic shock mesenteric lymph is an important contributor to cardiac dysfunction following hemorrhagic shock. .


Subject(s)
Animals , Male , Heart Diseases/etiology , Heart Diseases/physiopathology , Lymph/physiology , Mesentery/physiopathology , Shock, Hemorrhagic/complications , Shock, Hemorrhagic/physiopathology , Disease Models, Animal , Drainage/methods , Glucose , Heart Rate/physiology , Heart Ventricles/physiopathology , Mesentery/pathology , Random Allocation , Rats, Wistar , Reference Values , Time Factors , Tromethamine , Ventricular Pressure/physiology
15.
BMJ Case Rep ; 20142014 Oct 17.
Article in English | MEDLINE | ID: mdl-25326572

ABSTRACT

Mesenteric panniculitis pertains to a group of uncommon disorders named sclerosing mesenteritis that present with different levels of inflammation and fibrosis of the small bowel mesentery. It is associated with abdominal surgeries, trauma, malignancies, infections and connective tissue diseases. To the best of our knowledge, no cases of sclerosing mesenteritis have been reported in patients with systemic sclerosis. We present a case of a 61-year-old woman who had incidental CT findings of mesenteric panniculitis. Diagnosis was confirmed by biopsy that showed fat necrosis. On further review she had a 1-year history of Raynaud's phenomenon. Physical examination showed sclerodactyly. She had elevated anticentromere antibodies and skin biopsy was consistent with scleroderma. She was diagnosed with limited systemic sclerosis and was treated with D-penicillamine. After 6 years of follow-up, the mesenteric panniculitis and systemic sclerosis both remained stable. This case highlights the importance of considering rheumatic diseases in the differential diagnosis of sclerosing mesenteritis.


Subject(s)
Mesentery/diagnostic imaging , Panniculitis, Peritoneal/diagnostic imaging , Scleroderma, Systemic/diagnostic imaging , Antirheumatic Agents/therapeutic use , Biopsy , Diagnosis, Differential , Fat Necrosis/complications , Female , Follow-Up Studies , Humans , Mesentery/pathology , Middle Aged , Panniculitis, Peritoneal/complications , Panniculitis, Peritoneal/drug therapy , Penicillamine/therapeutic use , Raynaud Disease/complications , Scleroderma, Systemic/complications , Scleroderma, Systemic/drug therapy , Tomography, X-Ray Computed/methods
19.
Cell Tissue Res ; 353(3): 367-80, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23644765

ABSTRACT

The colocalization, number, and size of various classes of enteric neurons immunoreactive (IR) for the purinergic P2X2 and P2X7 receptors (P2X2R, P2X7R) were analyzed in the myenteric and submucosal plexuses of control, undernourished, and re-fed rats. Pregnant rats were exposed to undernourishment (protein-deprivation) or fed a control diet, and their offspring comprised the following experimental groups: rats exposed to a normal diet throughout gestation until postnatal day (P)42, rats protein-deprived throughout gestation and until P42, and rats protein-deprived throughout gestation until P21 and then given a normal diet until P42. Immunohistochemistry was performed on the myenteric and submucosal plexuses to evaluate immunoreactivity for P2X2R, P2X7R, nitric oxide synthase (NOS), choline acetyltransferase (ChAT), calbindin, and calretinin. Double-immunohistochemistry of the myenteric and submucosal plexuses demonstrated that 100% of NOS-IR, calbindin-IR, calretinin-IR, and ChAT-IR neurons in all groups also expressed P2X2R and P2X7R. Neuronal density increased in the myenteric and submucosal plexuses of undernourished rats compared with controls. The average size (profile area) of some types of neurons in the myenteric and submucosal plexuses was smaller in the undernourished than in the control animals. These changes appeared to be reversible, as animals initially undernourished but then fed a normal diet at P21 (re-feeding) were similar to controls. Thus, P2X2R and P2X7R are present in NOS-positive inhibitory neurons, calbindin- and calretinin-positive intrinsic primary afferent neurons, cholinergic secretomotor neurons, and vasomotor neurons in rats. Alterations in these neurons during undernourishment are reversible following re-feeding.


Subject(s)
Mesentery , Neurons/metabolism , Prenatal Exposure Delayed Effects/metabolism , Protein Deficiency/metabolism , Animals , Calbindin 2/metabolism , Calbindins/metabolism , Choline O-Acetyltransferase/metabolism , Female , Male , Mesentery/growth & development , Mesentery/innervation , Mesentery/metabolism , Mesentery/pathology , Nerve Tissue Proteins/metabolism , Neurons/pathology , Nitric Oxide Synthase/metabolism , Pregnancy , Prenatal Exposure Delayed Effects/pathology , Protein Deficiency/pathology , Rats , Rats, Wistar , Receptors, Purinergic P2X2/metabolism , Receptors, Purinergic P2X7/metabolism
20.
Reproduction ; 145(2): 119-26, 2013 Feb.
Article in English | MEDLINE | ID: mdl-23148086

ABSTRACT

Endometriosis is a benign gynecological disease. Cyclooxygenase-2 (COX-2) and aromatase proteins have been shown to be overexpressed in eutopic endometrium from women suffering from this disease compared to disease-free women. Furthermore, inhibition of these molecules individually was demonstrated to have antiproliferative and proapoptotic effects both in vitro and in vivo in several models. In this study, the effect of combining celecoxib, a selective COX-2 inhibitor, and anastrozole, an aromatase inhibitor, on the implantation and growth of endometriotic like lesions in a murine model of endometriosis was evaluated. Endometriosis was surgically induced in female BALB/c mice. After 28 days of treatment with celecoxib, anastrozole, or their combination, animals were killed and lesions were counted, measured, excised, and fixed. Immunohistochemistry for proliferating cell nuclear antigen and CD34 was performed for assessment of cell proliferation and vascularization. TUNEL technique was performed for apoptosis evaluation. Celecoxib was the only treatment to significantly reduce the number of lesions established per mouse, their size and vascularized area. In addition, cell proliferation was significantly diminished and apoptosis was significantly enhanced by both individual treatments. When the therapies were combined, they reversed their effects. These results confirm that celecoxib and anastrozole separately decrease endometriotic growth, but when combined they might have antagonizing effects.


Subject(s)
Endometriosis/drug therapy , Nitriles/therapeutic use , Peritoneal Diseases/drug therapy , Pyrazoles/therapeutic use , Sulfonamides/therapeutic use , Triazoles/therapeutic use , Uterine Diseases/drug therapy , Anastrozole , Animals , Aromatase Inhibitors/administration & dosage , Aromatase Inhibitors/adverse effects , Aromatase Inhibitors/therapeutic use , Celecoxib , Cyclooxygenase 2 Inhibitors/administration & dosage , Cyclooxygenase 2 Inhibitors/adverse effects , Cyclooxygenase 2 Inhibitors/therapeutic use , Drug Combinations , Drug Evaluation, Preclinical , Drug Incompatibility , Endometriosis/pathology , Female , Mesentery/pathology , Mice , Mice, Inbred BALB C , Nitriles/administration & dosage , Nitriles/adverse effects , Peritoneal Diseases/pathology , Pyrazoles/administration & dosage , Pyrazoles/adverse effects , Sulfonamides/administration & dosage , Sulfonamides/adverse effects , Triazoles/administration & dosage , Triazoles/adverse effects , Uterine Diseases/pathology
SELECTION OF CITATIONS
SEARCH DETAIL